Breaking News
Latest Blogs
Table of Contents
Volume 34, Issue 21 (February 17, 2026)
For full issue access, subscribers click here.
Article
Private Equity Investments in Lab Tool Companies Reflect New Realities
Executive Briefing
The latest on Waters, Avantor and more
Financial
Fourth Quarter Results: Bio-Techne, Illumina and Shimadzu
Market Profile
Spectrophotometers
Industry Watch
Government
Clinical and Government
Academia
Region Watch
China
India
Europe
News
Broad-Based Companies
Sequencing
Laboratory Products
Lab Automation
Lab Equipment
Consumables
Electrochemistry
Spectroscopy
Bottom Line
Companies’ latest financial results
The Trials and Tribulations of the US Academic and Government End-Market in 2025: Presentation Highlights from the 44th JPMorgan Healthcare Conference
On February 7, 2025, the Trump administration announced a 15% cap on all indirect costs for new and existing NIH grants. However, on April 4, 2025, the US District Court in Massachusetts enacted a preliminary injunction blocking the limit. In response, the HHS appealed the injunction to the US Court of Appeals for the First […]
Single Use Leads Bioreactor Market Growth
A new report from Strategic Directions International (SDi), a business intelligence firm specializing in the analytical instrument market, finds that the compound annual growth rate (CAGR) between 2024 and 2029 of demand in the cell and gene therapy (C>) market for seven categories of analytical technologies will expand in the high single digits. The technology […]
10x Genomics Debuts First Plate-Based Assay
10x Genomics has begun shipping its latest Flex assay for its Chromium instrument platform, responding to the needs of the single-cell sequencing market for easy to use, higher-throughput and scalable solutions. For example, the burgeoning field of cell atlases, or maps of an organism’s cells, requiring larger data sets and thus the faster generation of […]
Lab Tool Companies and Share Repurchases
Share repurchase programs have been a heavily discussed topic among investors and analysts, with some questioning their relationship to a company’s financial health. Among the leading reasons companies initiate share repurchase programs is to reduce the number of outstanding shares, thereby increasing the value of the remaining shares. Additionally, companies buy back shares to demonstrate […]
Precision Cell Systems: Bringing Companies Together to Share Resources
As the life science analytical instrument industry faces the challenges presented by uncertain government and academic funding and slower CapEx spending by biopharma companies, plus nervousness from potential investors, companies introducing new technology for life science research are facing a more difficult environment for raising money. Formed earlier this year, Precision Cell Systems (PCS) is […]